We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues Warning Letter to India’s Ipca Labs for Systemic Data Manipulation
FDA Issues Warning Letter to India’s Ipca Labs for Systemic Data Manipulation
The FDA has slammed yet another Indian drugmaker for data integrity issues: This time it rebuked Ipca Laboratories for data falsification at three of the company’s manufacturing facilities.